Hudson Bay Capital Management LP Buys 503,050 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Hudson Bay Capital Management LP grew its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 954.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 555,767 shares of the company's stock after buying an additional 503,050 shares during the quarter. Hudson Bay Capital Management LP owned 0.44% of Surgery Partners worth $11,766,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in SGRY. Franklin Resources Inc. raised its position in Surgery Partners by 19.5% in the third quarter. Franklin Resources Inc. now owns 21,324 shares of the company's stock worth $677,000 after acquiring an additional 3,487 shares during the period. JPMorgan Chase & Co. increased its holdings in Surgery Partners by 3.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 189,436 shares of the company's stock worth $6,107,000 after acquiring an additional 5,551 shares during the period. Harbor Capital Advisors Inc. grew its stake in Surgery Partners by 25.2% in the 4th quarter. Harbor Capital Advisors Inc. now owns 67,443 shares of the company's stock worth $1,428,000 after buying an additional 13,588 shares in the last quarter. Inspire Investing LLC grew its stake in Surgery Partners by 47.5% in the 4th quarter. Inspire Investing LLC now owns 19,034 shares of the company's stock worth $403,000 after buying an additional 6,131 shares in the last quarter. Finally, KBC Group NV grew its holdings in shares of Surgery Partners by 66.1% during the 4th quarter. KBC Group NV now owns 3,962 shares of the company's stock valued at $84,000 after purchasing an additional 1,577 shares during the last quarter.

Surgery Partners Stock Performance

NASDAQ SGRY traded up $0.30 during trading hours on Friday, hitting $23.94. 962,649 shares of the company's stock traded hands, compared to its average volume of 1,092,433. The business's fifty day moving average price is $22.55 and its two-hundred day moving average price is $23.19. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The firm has a market capitalization of $3.07 billion, a P/E ratio of -49.88, a P/E/G ratio of 19.21 and a beta of 1.96. Surgery Partners, Inc. has a 52 week low of $19.50 and a 52 week high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.08 by ($0.04). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $776.00 million for the quarter, compared to analysts' expectations of $777.77 million. During the same period in the prior year, the firm earned $0.10 EPS. Surgery Partners's revenue for the quarter was up 8.2% compared to the same quarter last year. Equities research analysts predict that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Insider Transactions at Surgery Partners

In related news, insider Marissa Brittenham sold 3,156 shares of the company's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the sale, the insider now owns 63,408 shares of the company's stock, valued at $1,527,498.72. This represents a 4.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO David T. Doherty sold 6,733 shares of the company's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.02, for a total transaction of $161,726.66. Following the sale, the chief financial officer now directly owns 150,868 shares in the company, valued at approximately $3,623,849.36. The trade was a 4.27% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.30% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on SGRY shares. Benchmark reissued a "buy" rating and issued a $35.00 price target on shares of Surgery Partners in a report on Monday, April 21st. Royal Bank of Canada restated an "outperform" rating and set a $35.00 price objective on shares of Surgery Partners in a research note on Tuesday, March 25th. Finally, Macquarie reduced their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research note on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $34.75.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.